QT
IMUX icon

Quantbot Technologies’s Immunic IMUX Stock Holding History

Quantbot Technologies’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$5K – 1894
2022
Q1 		$5K Sell
50
-200
-80% -$23.2K ﹤0.01% 1525
2021
Q4 		$23K Hold
250
– – ﹤0.01% 1199
2021
Q3 		$22K Buy
+250
New +$24.6K ﹤0.01% 1248

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Quantbot Technologies's IMUX Position: Q2 2022 in Review

Quantbot Technologies sold out of Immunic (IMUX) in Q2 2022, closing a stake of 50 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in IMUX in Q3 2021 and held it in 3 quarters. The position peaked at $23K in Q4 2021. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Quantbot Technologies reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 50 Immunic shares in Q2 2022, an estimated $5K.
  • Quantbot Technologies first reported a position in Immunic in Q3 2021 and held it in 3 quarters.
  • Quantbot Technologies's Immunic position peaked at $23K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.